selected publications
- Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile. Molecules (Basel, Switzerland). 2023 Academic Article GET IT
-
Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico Studies.
Molecules (Basel, Switzerland).
2022
Academic Article
GET IT
Times cited: 3 -
Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans.
Pathogens & immunity.
2022
Review
GET IT
Times cited: 6 - Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases. Open forum infectious diseases. 2022 Academic Article GET IT
-
Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling.
International journal of molecular sciences.
2022
Review
GET IT
Times cited: 3 -
Thiazole/Thiadiazole/Benzothiazole Based Thiazolidin-4-One Derivatives as Potential Inhibitors of Main Protease of SARS-CoV-2.
Molecules (Basel, Switzerland).
2022
Academic Article
GET IT
Times cited: 17 -
Novel antifungal agents in clinical trials.
F1000Research.
2021
Review
GET IT
Times cited: 24 -
5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation.
Bioorganic & medicinal chemistry.
2018
Academic Article
GET IT
Times cited: 57